{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T10:45:34Z","timestamp":1789469134995,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07147-1","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T16:36:55Z","timestamp":1782923815000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Early versus standard anti-thymocyte globulin administration in haploidentical transplantation using post-transplant cyclophosphamide: a pilot comparative study"],"prefix":"10.1007","volume":"105","author":[{"given":"Ghazaleh","family":"Kheiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Nejati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kobra Bagheri","family":"Valami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bita","family":"Shahrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Alijani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash Safari","family":"Sabet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Barkhordar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"1","key":"7147_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbmt.2015.11.001","volume":"22","author":"J Apperley","year":"2016","unstructured":"Apperley J, Niederwieser D, Huang X-j, Nagler A, Fuchs E, Szer J et al (2016) Haploidentical hematopoietic stem cell transplantation: a global overview comparing Asia, the European Union, and the United States. Biol Blood Marrow Transplant 22(1):23\u201326","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"7147_CR2","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1038\/bmt.2015.86","volume":"50","author":"Y Reisner","year":"2015","unstructured":"Reisner Y, Aversa F, Martelli M (2015) Haploidentical hematopoietic stem cell transplantation: state of art. Bone Marrow Transplant 50(2):S1\u2013S5","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"7147_CR3","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1182\/bloodadvances.2016001552","volume":"1","author":"N Kekre","year":"2017","unstructured":"Kekre N, Antin JH (2017) ATG in allogeneic stem cell transplantation: standard of care in 2017? Counterpoint. Blood Adv 1(9):573\u2013576","journal-title":"Blood Adv"},{"key":"7147_CR4","doi-asserted-by":"crossref","unstructured":"Chang Y-J, Huang X-J (eds) (2016) Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience. Seminars in hematology. Elsevier","DOI":"10.1053\/j.seminhematol.2016.01.004"},{"issue":"8","key":"7147_CR5","doi-asserted-by":"publisher","first-page":"3065","DOI":"10.1182\/blood-2005-05-2146","volume":"107","author":"D-P Lu","year":"2006","unstructured":"Lu D-P, Dong L, Wu T, Huang X-J, Zhang M-J, Han W et al (2006) Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched\/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation. Blood 107(8):3065\u20133073","journal-title":"Blood"},{"issue":"9","key":"7147_CR6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1016\/S1470-2045(09)70225-6","volume":"10","author":"J Finke","year":"2009","unstructured":"Finke J, Bethge WA, Schmoor C, Ottinger HD, Stelljes M, Zander AR et al (2009) Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial. Lancet Oncol 10(9):855\u2013864","journal-title":"Lancet Oncol"},{"issue":"6","key":"7147_CR7","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O\u2019Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M et al (2008) HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 14(6):641\u2013650","journal-title":"Biol Blood Marrow Transplant"},{"issue":"13","key":"7147_CR8","first-page":"2131","volume":"124","author":"S Ganguly","year":"2014","unstructured":"Ganguly S, Ross DB, Panoskaltsis-Mortari A, Kanakry CG, Blazar BR, Levy RB et al (2014) Donor CD4\u2009+\u2009Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice. Blood J Am Soc Hematol 124(13):2131\u20132141","journal-title":"Blood J Am Soc Hematol"},{"issue":"211","key":"7147_CR9","doi-asserted-by":"publisher","first-page":"211ra157","DOI":"10.1126\/scitranslmed.3006960","volume":"5","author":"CG Kanakry","year":"2013","unstructured":"Kanakry CG, Ganguly S, Zahurak M, Bola\u00f1os-Meade J, Thoburn C, Perkins B et al (2013) Aldehyde dehydrogenase expression drives human regulatory T cell resistance to posttransplantation cyclophosphamide. Sci Transl Med 5(211):211ra157\u2013211ra157","journal-title":"Sci Transl Med"},{"key":"7147_CR10","doi-asserted-by":"publisher","first-page":"921293","DOI":"10.3389\/fimmu.2022.921293","volume":"13","author":"M Barkhordar","year":"2022","unstructured":"Barkhordar M, Kasaeian A, Janbabai G, Kamranzadeh Fumani H, Tavakoli S, Rashidi AA et al (2022) Modified combination of anti-thymocyte globulin (ATG) and post-transplant cyclophosphamide (PTCy) as compared with standard ATG protocol in haploidentical peripheral blood stem cell transplantation for acute leukemia. Front Immunol 13:921293","journal-title":"Front Immunol"},{"issue":"2","key":"7147_CR11","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jtct.2021.10.012","volume":"28","author":"V Zelikson","year":"2022","unstructured":"Zelikson V, Simmons G, Raman N, Krieger E, Rebiero A, Hawks K et al (2022) Dynamical systems modeling of early-term immune reconstitution with different antithymocyte globulin administration schedules in allogeneic stem cell transplantation. Transplantation Cell therapy 28(2):85 e1-. e9","journal-title":"Transplantation Cell therapy"},{"key":"7147_CR12","first-page":"2025","volume":"16","author":"H Wang","year":"2025","unstructured":"Wang H, Yang H, Du J, Dou L, Liu D (2025) Optimizing anti-thymocyte globulin dosing in allogeneic hematopoietic stem cell transplantation: individualized approaches and clinical implications. Front Immunol 16:2025","journal-title":"Front Immunol"},{"issue":"8","key":"7147_CR13","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.jcyt.2025.05.009","volume":"27","author":"S Kuwano","year":"2025","unstructured":"Kuwano S, Terakura S, Imai K, Hirano S, Yokota H, Takeuchi Y et al (2025) Adjustment of low-dose ATG exposure improves outcomes in allogeneic hematopoietic stem cell transplantation: a prospective multicenter study. Cytotherapy 27(8):962\u2013972","journal-title":"Cytotherapy"},{"issue":"1","key":"7147_CR14","first-page":"126","volume":"123","author":"CA Lindemans","year":"2014","unstructured":"Lindemans CA, Chiesa R, Amrolia PJ, Rao K, Nikolajeva O, de Wildt A et al (2014) Impact of thymoglobulin prior to pediatric unrelated umbilical cord blood transplantation on immune reconstitution and clinical outcome. Blood J Am Soc Hematol 123(1):126\u2013132","journal-title":"Blood J Am Soc Hematol"},{"issue":"1","key":"7147_CR15","first-page":"51","volume":"15","author":"M Barkhordar","year":"2021","unstructured":"Barkhordar M, Kasaeian A, Tavakoli S, Vaezi M, Kamranzadeh Foumani H, Bahri T et al (2021) Selection of Suitable Alternative Donor in the Absence of Matched Sibling Donor: A Retrospective Single-Center Study to Compare between Haploidentical, 10\/10 and 9\/10 Unrelated Donor Transplantation. Int J Hematol Oncol Stem Cell Res 15(1):51\u201360","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"7147_CR16","doi-asserted-by":"publisher","first-page":"1339605","DOI":"10.3389\/fonc.2024.1339605","volume":"14","author":"M Azari","year":"2024","unstructured":"Azari M, Barkhordar M, Bahri T, Rad S, Kamranzadeh Fumani H, Mousavi SA et al (2024) Determining the predictive impact of donor parity on the outcomes of human leukocyte antigen matched hematopoietic stem cell transplants: a retrospective, single-center study. Front Oncol 14:1339605","journal-title":"Front Oncol"},{"issue":"6","key":"7147_CR17","doi-asserted-by":"publisher","first-page":"e0130026","DOI":"10.1371\/journal.pone.0130026","volume":"10","author":"S Servais","year":"2015","unstructured":"Servais S, Menten-Dedoyart C, Beguin Y, Seidel L, Gothot A, Daulne C et al (2015) Impact of Pre-Transplant Anti-T Cell Globulin (ATG) on Immune Recovery after Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation. PLoS ONE 10(6):e0130026","journal-title":"PLoS ONE"},{"issue":"6","key":"7147_CR18","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/s41409-020-0792-x","volume":"55","author":"F Bonifazi","year":"2020","unstructured":"Bonifazi F, Rubio M-T, Bacigalupo A, Boelens JJ, Finke J, Greinix H et al (2020) Rabbit ATG\/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel. Bone Marrow Transplant 55(6):1093\u20131102","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"7147_CR19","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.1182\/bloodadvances.2018030247","volume":"3","author":"R Dabas","year":"2019","unstructured":"Dabas R, Jamani K, Kangarloo SB, Dharmani-Khan P, Williamson TS, Ousia S et al (2019) Antirelapse effect of pretransplant exposure to rabbit antithymocyte globulin. Blood Adv 3(9):1394\u20131405","journal-title":"Blood Adv"},{"issue":"4","key":"7147_CR20","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/S2352-3026(17)30029-7","volume":"4","author":"R Admiraal","year":"2017","unstructured":"Admiraal R, Nierkens S, de Witte MA, Petersen EJ, Fleurke GJ, Verrest L et al (2017) Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a multicentre, retrospective, pharmacodynamic cohort analysis. Lancet Haematol 4(4):e183\u2013e91","journal-title":"Lancet Haematol"},{"issue":"6","key":"7147_CR21","first-page":"332e1","volume":"28","author":"H Wang","year":"2022","unstructured":"Wang H, Zhao Y, Fang S, Wang L, Peng B, Yang J et al (2022) Optimal Active Anti-Thymocyte Globulin Exposure Associated with Minimum Risk of Virus Reactivation and Comparable Acute Graft-Versus-Host Disease Under Adult Myeloablative Haploidentical Peripheral Blood Stem Cell Transplantation. Transpl Cell Ther 28(6):332e1\u2013e10","journal-title":"Transpl Cell Ther"},{"issue":"6","key":"7147_CR22","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.bbmt.2014.11.676","volume":"21","author":"J Storek","year":"2015","unstructured":"Storek J, Mohty M, Boelens JJ (2015) Rabbit anti-T cell globulin in allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transpl 21(6):959\u2013970","journal-title":"Biol Blood Marrow Transpl"},{"issue":"10","key":"7147_CR23","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/bmt.2015.148","volume":"50","author":"L Binkert","year":"2015","unstructured":"Binkert L, Medinger M, Halter J, Heim D, Gerull S, Holbro A et al (2015) Lower dose anti-thymocyte globulin for GvHD prophylaxis results in improved survival after allogeneic stem cell transplantation. Bone Marrow Transplant 50(10):1331\u20131336","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"7147_CR24","doi-asserted-by":"publisher","first-page":"E368","DOI":"10.1111\/ctr.12131","volume":"27","author":"M Remberger","year":"2013","unstructured":"Remberger M, Ringd\u00e9n O, H\u00e4gglund H, Svahn BM, Ljungman P, Uhlin M et al (2013) A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors. Clin Transplant 27(4):E368\u2013E74","journal-title":"Clin Transplant"},{"issue":"4","key":"7147_CR25","doi-asserted-by":"publisher","first-page":"e0284476","DOI":"10.1371\/journal.pone.0284476","volume":"18","author":"J Zuckermann","year":"2023","unstructured":"Zuckermann J, Castro BMd, Cunha TA, Paz A, Moreira LB (2023) Systematic review and meta-analysis of anti-thymocyte globulin dosage as a component of graft-versus-host disease prophylaxis. PLoS ONE 18(4):e0284476","journal-title":"PLoS ONE"},{"key":"7147_CR26","doi-asserted-by":"crossref","unstructured":"Gonzalez-Bocco IH, Cheng M, Aleissa MM, Arbona EI, Chen K, Zhou E et al (2022) Letermovir treatment for refractory or resistant cytomegalovirus infection or disease with concurrent organ dysfunction: an interim analysis of a phase 2 open label study. Open Forum Infect Dis 9(Supplement_2): 733.","DOI":"10.1093\/ofid\/ofac492.024"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07147-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07147-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07147-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:42:55Z","timestamp":1789465375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07147-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":26,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["7147"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07147-1","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"16 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors used AI-assisted language editing tools for grammar and clarity. The authors take full responsibility for the content.","order":2,"name":"Ethics","label":"Use of AI disclosure","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"368"}}